- Home
- DRTS vs NCZ Comparison
DRTS vs NCZ Comparison
Compare DRTS & NCZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRTS
- NCZ
- Stock Information
- Founded
- DRTS 2015
- NCZ 2003
- Country
- DRTS Israel
- NCZ United States
- Employees
- DRTS N/A
- NCZ N/A
- Industry
- DRTS Medical/Dental Instruments
- NCZ Finance Companies
- Sector
- DRTS Health Care
- NCZ Finance
- Exchange
- DRTS Nasdaq
- NCZ Nasdaq
- Market Cap
- DRTS 300.2M
- NCZ 271.0M
- IPO Year
- DRTS N/A
- NCZ N/A
- Fundamental
- Price
- DRTS $3.80
- NCZ $13.67
- Analyst Decision
- DRTS Strong Buy
- NCZ
- Analyst Count
- DRTS 1
- NCZ 0
- Target Price
- DRTS $9.00
- NCZ N/A
- AVG Volume (30 Days)
- DRTS 64.9K
- NCZ 533.0K
- Earning Date
- DRTS 11-18-2025
- NCZ 01-01-0001
- Dividend Yield
- DRTS N/A
- NCZ 12.16%
- EPS Growth
- DRTS N/A
- NCZ N/A
- EPS
- DRTS N/A
- NCZ N/A
- Revenue
- DRTS N/A
- NCZ N/A
- Revenue This Year
- DRTS N/A
- NCZ N/A
- Revenue Next Year
- DRTS N/A
- NCZ N/A
- P/E Ratio
- DRTS N/A
- NCZ N/A
- Revenue Growth
- DRTS N/A
- NCZ N/A
- 52 Week Low
- DRTS $2.14
- NCZ $2.50
- 52 Week High
- DRTS $4.69
- NCZ $3.15
- Technical
- Relative Strength Index (RSI)
- DRTS 41.23
- NCZ 41.25
- Support Level
- DRTS $3.75
- NCZ $13.79
- Resistance Level
- DRTS $4.07
- NCZ $14.36
- Average True Range (ATR)
- DRTS 0.23
- NCZ 0.23
- MACD
- DRTS -0.03
- NCZ -0.05
- Stochastic Oscillator
- DRTS 1.27
- NCZ 6.41
About DRTS Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.
About NCZ Virtus Convertible & Income Fund II of Beneficial Interest
Virtus Convertible & Income Fund II is a diversified, closed-end management investment company. The investment objective of the company is to provide total return through a combination of capital appreciation and high current income. Its portfolio of investments includes different sector investments such as in healthcare services, media, oil, gas, and consumable fuels and others.